CD24 and breast carcinoma: Originally identified as self-renewing cells in leukemia with a CD34+CD38- phenotype, they have since been identified in several solid and hematologic malignancies, including breast cancer, as both hyperproliferative and slow-cycling cells with a consensus CD44+CD24-/ALDH1+ phenotype[11].